Hemoclin Gel for the Treatment of Hemorrhoids

NCT05124379 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2022-03-31

No results posted yet for this study

Summary

Post market, single arm, clinical investigation to assess safety and performance of the product.

Conditions

  • Hemorrhoids Grade I and II

Interventions

DEVICE

Hemoclin Gel

Non sterile gel for intra-rectal use

Sponsors & Collaborators

  • Karo Pharma AB

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2021-11-17
Completion
2022-01-19

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05124379 on ClinicalTrials.gov